treatment of primary and secondary liver neoplasms
demonstrating higher long-term disease-free survival
rates than TPA (F. Romano 2012). In the
oncological TPA one of the main problems facing
doctors is the uncertainty about the actual size of the
ablations, mainly as a direct consequence of the
well-known "heat sink effect".
The prediction of this effect and of the 3D
dimensions of the ablation zone in relation to the
amount of applied microwave energy is a crucial
aspect since an incorrect prediction can lead to an
insufficient volume of ablation and a relapse of the
neoplasm. Since it is very hard to predict in practice
the exact size of the ablation for each combination of
time, power and size of the needle before the
execution of the procedure, these data are often
supplied to the doctor by the manufacturers of
thermal ablation systems in the form of ablation
charts or algorithms, but in our opinion these
information, together with the operator's personal
experience does not always provide the expected
results because they are often based on experiments
on ex-vivo organs at ambient temperature that
present serious deficiencies, preventing reliable
translation into the clinical practice.
In order to overcome these limitations, the
Department of Industrial Engineering (DIEF) of the
University of Florence has developed an
experimental platform (patent pending) to keep the
explanted liver in a state of normal physiological
thermal perfusion, capable to simulate the actual
heat sink effect during a TPA procedure. We need to
underline that the platform can simulate
physiological liver perfusion but is not able to keep
the liver cells alive and this aspect has been
evaluated by the authors before performing
experimental tests. Recent studies have underlined
that a warm ischemia time up to 60min does not
generate any irreversible cellular change and is
acceptable even for hepatic transplant
(Kalisvaart,
2018).As a consequence of that, if the ablation
experiment is performed in 60min beginning from
the liver explant, the effect of liver warm ischemia
on ablation shape and dimensions is negligible or
even absent. The aim of the study was therefore to
extract preliminary data to be compared with the
literature data in vivo. In our opinion, the ex-vivo
pig perfused liver test should represent the gold
standard for the definition of truly reliable
algorithms and ablation charts for the following
reasons:
1. The test is easily reproducible and allows a
definitive evaluation of the ablation volume in
the presence of the heat sink effect;
2. The proposed approach could allow the
standardization of the experimental procedure to
extract reliable algorithms and ablation charts;
3. The economic burden is lower than the costly in
vivo animal procedures.
4. Important ethical implications can be overcome.
In order to confirm experimentally this belief, the
ablation experiments where made in two different
perfusion inflow states: active and blocked using the
UniFi Hepatic Flow platform.
Ablation results of the two inflow state are
depicted in Tab1.
Preliminary results obtained by comparing
ablation performed in blocked and active perfusion
states show a reduction of about 30% in the ablation
radius from one to the other state, regardless of the
size of the applicator.
The ablation zones in this study where
commensurate with those of previous studies (M.
Dimitri 2018) obtaining results that confirm the
substantial equivalence between in-vivo and ex-vivo
normothermic perfused liver for the same energy
delivery.
It is important to note that the electromagnetic
and thermal properties of the ex vivo liver at
ambient temperature normally used by
manufacturers to extract the ablation chart, are very
different from those of the ex vivo normothermic
perfused liver.
7 CONCLUSION
The preliminary results obtained with this study are
too limited to have a statistical relevance but if this
result will be confirmed even in future tests this
model could constitute the best procedure to
evaluate the effectiveness of TPA without the use of
in vivo animal models. The availability of a
standardized ablation model based on ex-vivo
perfused liver opens the way to a more in-depth
investigation of the heat sink effect at peripheral and
central vessel locations. The UNIFI Perfusion
Platform is very versatile and it allows to easily
change the composition and flow rate of the
perfusion solution of the liver parenchyma.
Moreover this model could be used to emulate an
open surgical ablation, allowing the surgeon to
rotate the liver within its anatomical surrounding,
manually protect heat-sensitive organs (bowel) and
easily insert clustered applicators to treat large non
spherical tumors.